GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Active, not recruiting · NCT04472910 · Registry updated 2026-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Active, not recruiting | Not applicable | 2026-03-12 | NCT04472910 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pancreatic Cancer Canada | 1 |
| University Health Network, Toronto | 417 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer Agency Vancouver | Vancouver | Canada | 1 |
| Jewish General Hospital | Montreal | Canada | 20 |
| Kingston Health Sciences Centre | Kingston | Canada | 9 |
| London Health Sciences Centre | London | Canada | 39 |
| Ottawa Hospital | Ottawa | Canada | 2 |
| Princess Margaret Cancer Centre | Toronto | Canada | 1 |
| Sunnybrook Hospital/Odette Cancer Centre | Toronto | Canada | 1 |
| Unity Health (St. Joseph's and St. Michael's) | Toronto | Canada | 1 |